FDA Inspection
Carter BloodCare ParisCarter BloodCare Paris – FDA Inspection, Aug 13, 2009
Record Details
This FDA Inspection record concerns Carter BloodCare Paris, with an inspection on August 13, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Carter BloodCare Paris
- Inspection Date
- August 13, 2009
- Product Type
- Biologics
View Company Profile
ID · c50eb9c1-8c1a-49b3-a6cb-552439eaad91
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 604692
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Carter BloodCare Paris
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 25, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 9, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 11, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 14, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare Paris
- FDA Inspection 1119839 - 2020-02-25
- FDA Inspection 1041613 - 2018-02-09
- FDA Inspection 810140 - 2012-12-11
- FDA Inspection 729702 - 2011-06-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.